State-funded venture capital firm Connecticut Innovations has launched a $200m fund to stimulate the state’s bioscience sector. Grants, equity investments and loans will all be available to bioscience-related ventures over the next ten years, following the passing of Senate Bill 842. The funds will be primarily be used to assist startups and university spin-outs cross…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
